Northridge, CA and Cambridge, UK, 28 January 2015. Link here. Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company’s Pivotal Phase III burn trial for ReCell®. The FDA-approved study is designed to confirm the safety and […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-01-28 17:58:322018-01-06 17:59:05Avita Medical Announces First Patient Enrolment in US Pivotal Study of ReCell® for the Treatment of Burns
By Dylan Bushell-Embling | Posted in Medical devices on 22 January, 2015 Australian Life Scientist. Link here. A new smart inhaler developed by respiratory technology company Nexus6 has been demonstrated to encourage child asthmatics to take medication. Children using the SmartTrack inhaler, which incorporates an audio reminder function into standard inhaler technology, were 180% more likely to […]
London Live – link here. Maleena Pone – 16th January 2015 Nicholas Fearon, known as ‘Pikki’, is a London-based film producer. With the support of the REX robot, Pikki will walk for the first time since he battled back from life threatening injuries he sustained in an accident 11 years ago. He was told by doctors […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-01-16 18:02:482018-01-06 18:03:16RXB – Robotic suit helps paralysed film director walk again
Bacteriophage-based Antibacterial Therapies to Treat Drug Resistant Infections Advancing towards Human Clinical Studies 2015 Uplisting to Major Exchange Expected Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, January 05, 2015 – Link here. AmpliPhi BioSciences Corporation (OTCQB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, provided an update to […]
By Renaissance Capital, December 30, 2014 Link here. Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, filed on Tuesday with the SEC to raise up to $60 million in an initial public offering. The Dublin, Ireland-based company, which was founded in 2010, plans to list on the NASDAQ […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-12-30 18:00:272018-01-06 18:01:15Pet therapeutic company Nexvet files for a $60 million IPO – Nasdaq
ITV Report link here. 22 December 2014 A physiotherapy service in Northamptonshire is giving people the chance to walk again with the world’s first self-supporting robotic exoskeleton. The device means people with mobility problems can move around without crutches or a walking frame. It’s got the backing of Winter Paralympic star Anna Turney who broke her back while snowboarding. […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-12-22 18:02:002018-01-06 18:02:38RXB – Northamptonshire: “Miracle” exoskeleton gives disabled people the chance to walk again
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-12-06 18:03:262018-01-06 18:04:43Nexvet December 2014 Newsletter – Paws for Thought
DUBLIN, Ireland; MELBOURNE, Australia –‐ December 3, 2014. Link here. Veterinary biologic therapy developer Nexvet Biopharma today announced the signing of a ten year collaboration and distribution agreement with Virbac (EPA:VIRP), one of the largest animal health dedicated companies in the world. Under the terms of the agreement, Virbac will distribute NV-01, Nexvet’s most advanced product, […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-12-03 18:06:072018-01-06 18:06:40Nexvet Announces Collaboration and Distribution Agreement with Virbac
4 November 2014. Link here. The update includes: – Work begins on the new fish oil refinery; – Strengthening the SeaDragon bench; – Food industry veteran joins the SeaDragon board; – The good oil – a word from SeaDragon Chief Executive, Ross Keeley. Contact Ross Keeley SeaDragon Chief Executive Officer Telephone: 03 547 0336
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2014-10-09 18:07:262018-01-06 18:07:55Rex Bionics was winner of ‘Best Technology Award’ at the AIM Awards 2014
Avita Medical Announces First Patient Enrolment in US Pivotal Study of ReCell® for the Treatment of Burns
/in Avita Medical, Portfolio CompaniesNorthridge, CA and Cambridge, UK, 28 January 2015. Link here. Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company’s Pivotal Phase III burn trial for ReCell®. The FDA-approved study is designed to confirm the safety and […]
Smart inhaler helps asthmatic kids breathe easier
/in Portfolio CompaniesBy Dylan Bushell-Embling | Posted in Medical devices on 22 January, 2015 Australian Life Scientist. Link here. A new smart inhaler developed by respiratory technology company Nexus6 has been demonstrated to encourage child asthmatics to take medication. Children using the SmartTrack inhaler, which incorporates an audio reminder function into standard inhaler technology, were 180% more likely to […]
RXB – Robotic suit helps paralysed film director walk again
/in Portfolio CompaniesLondon Live – link here. Maleena Pone – 16th January 2015 Nicholas Fearon, known as ‘Pikki’, is a London-based film producer. With the support of the REX robot, Pikki will walk for the first time since he battled back from life threatening injuries he sustained in an accident 11 years ago. He was told by doctors […]
AmpliPhi Provides Shareholder Update
/in Armata Pharmaceuticals, Portfolio CompaniesBacteriophage-based Antibacterial Therapies to Treat Drug Resistant Infections Advancing towards Human Clinical Studies 2015 Uplisting to Major Exchange Expected Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, January 05, 2015 – Link here. AmpliPhi BioSciences Corporation (OTCQB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, provided an update to […]
Pet therapeutic company Nexvet files for a $60 million IPO – Nasdaq
/in Pharmamark, Portfolio CompaniesBy Renaissance Capital, December 30, 2014 Link here. Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, filed on Tuesday with the SEC to raise up to $60 million in an initial public offering. The Dublin, Ireland-based company, which was founded in 2010, plans to list on the NASDAQ […]
RXB – Northamptonshire: “Miracle” exoskeleton gives disabled people the chance to walk again
/in Portfolio CompaniesITV Report link here. 22 December 2014 A physiotherapy service in Northamptonshire is giving people the chance to walk again with the world’s first self-supporting robotic exoskeleton. The device means people with mobility problems can move around without crutches or a walking frame. It’s got the backing of Winter Paralympic star Anna Turney who broke her back while snowboarding. […]
Nexvet December 2014 Newsletter – Paws for Thought
/in Pharmamark, Portfolio CompaniesDecember 2014 – link here.
Nexvet Announces Collaboration and Distribution Agreement with Virbac
/in Pharmamark, Portfolio CompaniesDUBLIN, Ireland; MELBOURNE, Australia –‐ December 3, 2014. Link here. Veterinary biologic therapy developer Nexvet Biopharma today announced the signing of a ten year collaboration and distribution agreement with Virbac (EPA:VIRP), one of the largest animal health dedicated companies in the world. Under the terms of the agreement, Virbac will distribute NV-01, Nexvet’s most advanced product, […]
SeaDragon Investor Update November 2014
/in Portfolio Companies, SeaDragon4 November 2014. Link here. The update includes: – Work begins on the new fish oil refinery; – Strengthening the SeaDragon bench; – Food industry veteran joins the SeaDragon board; – The good oil – a word from SeaDragon Chief Executive, Ross Keeley. Contact Ross Keeley SeaDragon Chief Executive Officer Telephone: 03 547 0336
Rex Bionics was winner of ‘Best Technology Award’ at the AIM Awards 2014
/in Portfolio Companies, Rex BionicsLink here. 2014 AIM WINNERS – Best Technology Award. Announced at the AIM Awards ceremony on 9 October 2014.